{
     "PMID": "16259761",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20060418",
     "LR": "20151119",
     "IS": "0022-3573 (Print) 0022-3573 (Linking)",
     "VI": "57",
     "IP": "10",
     "DP": "2005 Oct",
     "TI": "Design and synthesis of long-chain arylpiperazines with mixed affinity for serotonin transporter (SERT) and 5-HT(1A) receptor.",
     "PG": "1319-27",
     "AB": "A new generation of antidepressant agents could be represented by compounds with mixed activity as serotonin transporter (SERT) inhibitors and 5-HT(1A) receptor antagonists. We report here on the synthesis and evaluation of SERT and 5-HT(1A) receptor affinity of long-chain arylpiperazines obtained either by modifying 6-nitroquipazine into a long-chain arylpiperazine or by inserting a modified 6-nitroquipazine moiety or other structures endowed with SERT affinity into a long-chain arylpiperazine with 5-HT(1A) affinity. Among the compounds studied, 2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-(6-nitro-2-quinolyl)ethylamine (21) and 1-(5-bromo-1,2,3,4-tetrahydronaphthalen-1-yl)-3-[4-(2-methoxyphenyl)-piperazin-1- yl]-1-propanone (24) showed good affinity values for SERT and 5-HT(1A) receptors (SERT: K(i) (inhibition constant)=71.8 and 62.8 nM; 5-HT(1A)K(i)=14.2 and 0.82 nM, respectively).",
     "FAU": [
          "Perrone, Roberto",
          "Berardi, Francesco",
          "Colabufo, Nicola A",
          "Lacivita, Enza",
          "Larizza, Carmela",
          "Leopoldo, Marcello",
          "Tortorella, Vincenzo"
     ],
     "AU": [
          "Perrone R",
          "Berardi F",
          "Colabufo NA",
          "Lacivita E",
          "Larizza C",
          "Leopoldo M",
          "Tortorella V"
     ],
     "AD": "Dipartimento Farmaco-Chimico, Universita degli Studi di Bari, via Orabona 4, 70125 Bari, Italy. perrone@farmchim.uniba.it",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "PL": "England",
     "TA": "J Pharm Pharmacol",
     "JT": "The Journal of pharmacy and pharmacology",
     "JID": "0376363",
     "RN": [
          "0",
          "(1-(5-bromo-1,2,3,4-tetrahydronaphthalen-1-yl)-3-(4-(2-methoxyphenyl)-piperazin-1",
          "-yl)-1-propanone)",
          "0 (2-(4-(2-methoxyphenyl)piperazin-1-yl)-N-(6-nitro-2-quinolyl)ethyamine)",
          "0 (Ethylamines)",
          "0 (Naphthalenes)",
          "0 (Piperazines)",
          "0 (Pyridines)",
          "0 (Serotonin 5-HT1 Receptor Agonists)",
          "0 (Serotonin 5-HT1 Receptor Antagonists)",
          "0 (Serotonin Antagonists)",
          "0 (Serotonin Plasma Membrane Transport Proteins)",
          "0 (Serotonin Receptor Agonists)",
          "10028-17-8 (Tritium)",
          "112692-38-3 (Receptor, Serotonin, 5-HT1A)",
          "333DO1RDJY (Serotonin)",
          "4WCY05C0SJ (Quipazine)",
          "71IH826FEG",
          "(N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxa",
          "mide)",
          "77372-73-7 (6-nitroquipazine)",
          "T75W9911L6 (Propane)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Binding, Competitive",
          "*Drug Design",
          "Ethylamines/chemical synthesis/pharmacology",
          "Guinea Pigs",
          "Hippocampus/drug effects/metabolism",
          "Humans",
          "Ileum/drug effects/metabolism",
          "Male",
          "Naphthalenes/chemical synthesis/pharmacology",
          "Piperazines/*chemical synthesis/metabolism/pharmacology",
          "Propane/analogs & derivatives/chemical synthesis/pharmacology",
          "Pyridines/pharmacology",
          "Quipazine/analogs & derivatives/chemistry",
          "Rats",
          "Rats, Wistar",
          "Receptor, Serotonin, 5-HT1A/*metabolism",
          "Serotonin/pharmacology",
          "Serotonin 5-HT1 Receptor Agonists",
          "Serotonin 5-HT1 Receptor Antagonists",
          "Serotonin Antagonists/pharmacology",
          "Serotonin Plasma Membrane Transport Proteins/*metabolism",
          "Serotonin Receptor Agonists/pharmacology",
          "Synaptosomes/drug effects/metabolism",
          "Tritium"
     ],
     "EDAT": "2005/11/02 09:00",
     "MHDA": "2006/04/19 09:00",
     "CRDT": [
          "2005/11/02 09:00"
     ],
     "PHST": [
          "2005/11/02 09:00 [pubmed]",
          "2006/04/19 09:00 [medline]",
          "2005/11/02 09:00 [entrez]"
     ],
     "AID": [
          "10.1211/jpp.57.10.0011 [doi]"
     ],
     "PST": "ppublish",
     "SO": "J Pharm Pharmacol. 2005 Oct;57(10):1319-27. doi: 10.1211/jpp.57.10.0011.",
     "term": "hippocampus"
}